Publications by authors named "Yuriko Shimizu"

Claim this Profile
A
Association Between CKAP4 Expression and Poor Prognosis in Patients with Bladder Cancer Treated with Radical Cystectomy.
Hiroki Katsumata, Dai Koguchi, Shuhei Hirano, Anna Suzuki, Kengo Yanagita, Yuriko Shimizu

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy.
Hiroki Katsumata, Kazumasa Matsumoto, Kengo Yanagita, Yuriko Shimizu, Shuhei Hirano

Int J Mol Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Membranous Expression of Heart Development Protein with EGF-like Domain 1 Is Associated with a Good Prognosis in Patients with Bladder Cancer.
Kohei Mori, Kazumasa Matsumoto, Masaomi Ikeda, Dai Koguchi, Yuriko Shimizu

Diagnostics (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine-Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy.
Dai Koguchi, Kazumasa Matsumoto, Masaomi Ikeda, Yuriko Shimizu, Marie Nakamura

Int J Mol Sci· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer.
Shuhei Hirano, Kazumasa Matsumoto, Kei Tanaka, Noriyuki Amano, Dai Koguchi, Yuriko Shimizu

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer.
Kohei Mori, Kazumasa Matsumoto, Noriyuki Amano, Dai Koguchi, Soichiro Shimura, Yuriko Shimizu

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer.
Soichiro Shimura, Kazumasa Matsumoto, Yuriko Shimizu, Kohei Mochizuki, Yutaka Shiono

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy.
Dai Koguchi, Kazumasa Matsumoto, Yuriko Shimizu, Momoko Kobayashi, Shuhei Hirano

Cancers (Basel)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy.
Yasukiyo Murakami, Kazumasa Matsumoto, Yuriko Shimizu, Masaomi Ikeda, Noriyuki Amano

Urol Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy.
Noriyuki Amano, Kazumasa Matsumoto, Yuriko Shimizu, Marie Nakamura, Hideyasu Tsumura

Urol Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electronic nose to distinguish bladder cancer by urinary odour feature: A pilot study.
Kazumasa Matsumoto, Yasukiyo Murakami, Yuriko Shimizu, Takahiro Hirayama, Wataru Ishikawa

Cancer Biomark· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomy.
Megumi Nomura, Kazumasa Matsumoto, Yuriko Shimizu, Masaomi Ikeda, Noriyuki Amano

Cancer Biomark· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression.
Shigenobu Kanba, Mitsukuni Murasaki, Tsukasa Koyama, Masahiro Takeuchi, Yuriko Shimizu

BMC Psychiatry· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression.
Mitsukuni Murasaki, Tsukasa Koyama, Shigenobu Kanba, Masahiro Takeuchi, Yuriko Shimizu

Psychopharmacology (Berl)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Multi-center, randomized, double-blind, placebocontrolled study of quetiapine extended-release formulation in Japanese patients with bipolar depression.
Mitsukuni Murasaki, Tsukasa Koyama, Shigenobu Kanba, Masahiro Takeuchi, Yuriko Shimizu

Psychopharmacology (Berl)· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased protein level of PEPT1 intestinal H+-peptide cotransporter upregulates absorption of glycylsarcosine and ceftibuten in 5/6 nephrectomized rats.
Yuriko Shimizu, Satohiro Masuda, Kumiko Nishihara, Lin Ji, Masahiro Okuda

Am J Physiol Gastrointest Liver Physiol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis